- N/T
Triall TRL
Nos falta información precisa de comercio.
Esto podría atribuirse a varias razones, incluida la liquidez limitada en el intercambio o la eliminación de la lista. O podría deberse a la incapacidad de proporcionar soporte para los intercambios donde este activo es actualmente negociable.
Capital.
$100,872.05Ranking #--FDV
--Ranking #--Inversores
Seguidores de X
Rendimiento de X
145WeakClasificar por X #10898- 0
- 100
- 500
- 1000
- 1500
Acerca de TRL
Triall is a company that provides innovative software and services to clinical researchers and patients involved in clinical trials. Clinical trials are research studies that evaluate the safety and effectiveness of new treatments before they can be approved for use in the market.
What makes Triall unique?
Triall is unique compared to other cryptocurrencies because it is specifically designed for the healthcare and clinical trial industry. It offers a platform-native means of payment for software and services related to clinical trials. This focus on the healthcare sector sets Triall apart from other cryptocurrencies that may have a broader range of applications. Additionally, Triall's token, TRL, is a key building block for its future vision of a self-sustaining digital ecosystem where data resources can be exchanged fairly and securely between patients, clinical trial sponsors, and service providers. This emphasis on creating a secure and equitable exchange of data resources further distinguishes Triall from other cryptocurrencies.